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Abstract
© 2018, Pharmainfo Publications. All rights reserved. Background—Atrial fibrillation (AF) is the
most  common  arrhythmia  often  associated  with  cardioembolic  stroke.  Hypothesis—We
investigated cases of AF first diagnosed (fdAF) in the acute phase of stroke.This type of AF might
be common, and might suggest poor prognosis for patients. Methods— Following screening
(n=1291)  661  patients  with  AF  and  a  history  of  stroke  were  enrolled  in  this  open-label,
prospective study; patient average age was 68.0 years. Results—A high level of co-morbidity
was observed: hypertension (in 100% of patients), ischemic heart disease (in 61.4% of patients),
diabetes mellitus (in 52.3% of patients), and chronic kidney disease (in 32.1% of patients). In
154 (23.3%) patients AF was first diagnosed at the onset of cardioembolic stroke. The HAS-BLED
score,  age,  hypertension  and  ischemic  heart  disease  rates  among  these  patients  were
comparable with the rest of the group; however, the percentage of patients with chronic kidney
disease, diabetes mellitus or myocardial infarction was significantly higher. The highest one-
year death rate was seen in patients with fdAF (death reported in 46 [29.9%] patients). The age
of patients with fdAF who died was significantly higher, and their neurological disorders were
more severe.  Conclusions—The results show a high rate of  fdAF and its poor prognosis in
patients with cardioembolic  stroke.  Thus,  the term “first  diagnosed stroke-associated atrial
fibrillation” seems relevant. The described condition has a negative predictive value, and is also
associated with high co-morbidity burden in patients with fdAF.
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